These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11467325)

  • 21. IGF-I and diabetes in adolescence.
    Dunger DB; Acerini CL
    Diabetes Metab; 1998 Apr; 24(2):101-7. PubMed ID: 9592633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biological and clinical analyses of the mechanism of growth retardation and the effect of recombinant human insulin-like growth factor-1 (rhIGF-1) treatment on glucose metabolism and growth in leprechaunism with severe insulin resistant diabetes].
    Kato M
    Hokkaido Igaku Zasshi; 1998 Nov; 73(6):613-25. PubMed ID: 10036618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism.
    Nakae J; Kato M; Murashita M; Shinohara N; Tajima T; Fujieda K
    J Clin Endocrinol Metab; 1998 Feb; 83(2):542-9. PubMed ID: 9467572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
    Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG
    J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated.
    Näntö-Salonen K; Muller HL; Hoffman AR; Vu TH; Rosenfeld RG
    Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes.
    Clemmons DR; Sleevi M; Allan G; Sommer A
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2652-8. PubMed ID: 17426090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic applications of the insulin-like growth factors.
    Savage MO; Camacho-Hübner C; Dunger DB
    Growth Horm IGF Res; 2004 Aug; 14(4):301-8. PubMed ID: 15231299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins.
    Feldmann B; Jehle PM; Mohan S; Lang GE; Lang GK; Brueckel J; Boehm BO
    Growth Horm IGF Res; 2000 Feb; 10(1):53-9. PubMed ID: 10753593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant IGF-I therapy in insulin-dependent diabetes mellitus.
    Savage MO; Dunger DB
    Diabetes Metab; 1996 Jul; 22(4):257-60. PubMed ID: 8767172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P; Brismar K; Rosenfeld RG; Hall K
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factor (IGF)-I and -II and IGF-binding proteins-1, -2, and -3 in children and adolescents with diabetes mellitus: correlation with metabolic control and height attainment.
    Strasser-Vogel B; Blum WF; Past R; Kessler U; Hoeflich A; Meiler B; Kiess W
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1207-13. PubMed ID: 7536202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus.
    Pennisi P; Gavrilova O; Setser-Portas J; Jou W; Santopietro S; Clemmons D; Yakar S; LeRoith D
    Endocrinology; 2006 Jun; 147(6):2619-30. PubMed ID: 16513827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of IGF-I and its binding proteins in the development of type 2 diabetes and cardiovascular disease.
    Ezzat VA; Duncan ER; Wheatcroft SB; Kearney MT
    Diabetes Obes Metab; 2008 Mar; 10(3):198-211. PubMed ID: 18269635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant human insulin-like growth factor I (IGF-I): risks and benefits of normalizing blood IGF-I concentrations.
    Clark RG
    Horm Res; 2004; 62 Suppl 1():93-100. PubMed ID: 15761240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in the renal complications of diabetes.
    Flyvbjerg A
    Kidney Int Suppl; 1997 Sep; 60():S12-9. PubMed ID: 9285896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The IGF system in childhood: physiology and clinical implications.
    Pozo J; Martos-Moreno GA; Barrios V; Argente J
    J Endocrinol Invest; 2005; 28(5 Suppl):38-42. PubMed ID: 16114274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of glucocorticoids on circulating levels and hepatic expression of insulin-like growth factor (IGF)-binding proteins and IGF-I in the adrenalectomized streptozotocin-diabetic rat.
    Unterman TG; Jentel JJ; Oehler DT; Lacson RG; Hofert JF
    Endocrinology; 1993 Dec; 133(6):2531-9. PubMed ID: 7694841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
    Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H
    J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term growth hormone or IGF-I administration improves the IGF-IGFBP system in arthritic rats.
    López-Menduiña M; Martín AI; Castillero E; Villanúa MA; López-Calderón A
    Growth Horm IGF Res; 2012 Feb; 22(1):22-9. PubMed ID: 22244673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).
    López-Bermejo A; Khosravi J; Fernández-Real JM; Hwa V; Pratt KL; Casamitjana R; Garcia-Gil MM; Rosenfeld RG; Ricart W
    Diabetes; 2006 Aug; 55(8):2333-9. PubMed ID: 16873698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.